Total Payments
$276,261
2023 Payments
$23.10
Companies
20
Transactions
470
Payment Breakdown by Category
Other$222,967 (80.7%)
Consulting$34,273 (12.4%)
Travel$11,274 (4.1%)
Food & Beverage$7,740 (2.8%)
Education$6.04 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $222,518 | 78 | 80.5% |
| Consulting Fee | $34,273 | 14 | 12.4% |
| Travel and Lodging | $11,274 | 65 | 4.1% |
| Food and Beverage | $7,740 | 310 | 2.8% |
| Honoraria | $450.00 | 1 | 0.2% |
| Education | $6.04 | 2 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $203,515 | 210 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $20,477 | 35 | $0 (2022) |
| GENZYME CORPORATION | $12,399 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $10,278 | 18 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $7,992 | 45 | $0 (2022) |
| Lilly USA, LLC | $6,789 | 9 | $0 (2021) |
| Edwards Lifesciences Corporation | $4,950 | 2 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $4,700 | 15 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $3,669 | 16 | $0 (2021) |
| Gilead Sciences, Inc. | $380.31 | 48 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $23.10 | 1 | CARDIVA MEDICAL, INC. ($23.10) |
| 2022 | $36,255 | 20 | PFIZER INC. ($29,452) |
| 2021 | $61,094 | 25 | PFIZER INC. ($37,400) |
| 2020 | $77,739 | 62 | PFIZER INC. ($58,921) |
| 2019 | $77,537 | 114 | PFIZER INC. ($62,414) |
| 2018 | $21,865 | 112 | PFIZER INC. ($15,170) |
| 2017 | $1,748 | 136 | Novartis Pharmaceuticals Corporation ($336.64) |
All Payment Transactions
470 individual payment records from CMS Open Payments — Page 1 of 19
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2023 | CARDIVA MEDICAL, INC. | CARDIVA VASCADE 6/7F VCS (Device) | Food and Beverage | In-kind items and services | $23.10 | General |
| Category: DEVICES | ||||||
| 12/06/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,655.00 | General |
| Category: Cardiovascular | ||||||
| 11/30/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $123.06 | General |
| Category: Cardiovascular | ||||||
| 11/22/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/10/2022 | E.R. Squibb & Sons, L.L.C. | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 11/09/2022 | Pfizer Inc. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2022 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $798.02 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/03/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $94.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/01/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,150.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/28/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/27/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $92.92 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/26/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/29/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/25/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $91.59 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/26/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Consulting Fee | Cash or cash equivalent | $2,725.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/03/2022 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/29/2022 | Pfizer Inc. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $38.61 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/29/2022 | Pfizer Inc. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/29/2022 | Pfizer Inc. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $11.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/22/2022 | Pfizer Inc. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,500.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/14/2022 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $63.45 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/23/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/08/2021 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $8,874.00 | General |
| 10/28/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/11/2021 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: CARDIOVASCULAR | ||||||
About Dr. Sameer Amin, MD
Dr. Sameer Amin, MD is a Internal Medicine healthcare provider based in Downey, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/21/2007. The National Provider Identifier (NPI) number assigned to this provider is 1326164633.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sameer Amin, MD has received a total of $276,261 in payments from pharmaceutical and medical device companies, with $23.10 received in 2023. These payments were reported across 470 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($222,518).
Ad
Practice Information
- Specialty Internal Medicine
- Location Downey, CA
- Active Since 03/21/2007
- Last Updated 02/03/2023
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1326164633
Products in Payments
- ELIQUIS (Drug) $115,763
- VYNDAQEL (Drug) $103,599
- JARDIANCE (Drug) $16,977
- LEQVIO (Drug) $4,580
- DISEASE STATE (Drug) $4,469
- DUPIXENT (Biological) $3,525
- FARXIGA (Drug) $3,501
- ENTRESTO (Drug) $497.05
- XARELTO (Drug) $360.77
- PRALUENT (Drug) $230.82
- Corlanor (Drug) $209.71
- CHANTIX (Drug) $169.05
- BRILINTA (Drug) $168.44
- Repatha (Biological) $130.09
- LEXISCAN (Drug) $75.07
- LifeVest (Device) $73.32
- PRADAXA (Drug) $56.51
- Lexiscan (Drug) $40.72
- WATCHMAN DEVICE (Device) $39.22
- PRALUENT ALIROCUMAB INJECTION (Biological) $37.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Downey
Eddie Thara, D.o, D.O
Internal Medicine — Payments: $33,607
Internal Medicine $33,607
Alan Frischer, M.d, M.D
Internal Medicine — Payments: $31,144
Internal Medicine $31,144
Dr. Laura Ryan, M.d, M.D
Internal Medicine — Payments: $13,695
Internal Medicine $13,695
Dr. Domingo Barrientos, M.d, M.D
Internal Medicine — Payments: $10,819
Internal Medicine $10,819
Dr. Hossein Eftekhari, Md, MD
Internal Medicine — Payments: $10,456
Internal Medicine $10,456
Hyong Kim, M.d, M.D
Internal Medicine — Payments: $10,296
Internal Medicine $10,296